Clinical Trial Update: MaCRA Part B in Côte d'Ivoire [NA]

View source ↗

Summary

A PATH-sponsored MaCRA Part B trial in Côte d'Ivoire for malaria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: PATH | Conditions: Malaria | NA | Status: WITHDRAWN